Upregulation of the high mobility group AT-hook 2 gene in acute aortic dissection is potentially associated with endothelial-mesenchymal transition

Histology and Histopathology

Volumn 26, Issue 8, 2011, Pages 1029-1037

  Belge, Gazanfer ^a   Radtke, Arlo ^a,b   Meyer, Anke ^a   Stegen, Isabel ^a   Richardt, Doreen ^b   Nimzyk, Rolf ^a   Nigam, Vishal ^c   Dendorfer, Andreas ^d   Sievers, Hans H ^b   Tiemann, Markus ^e   Buchwalow, Igor ^e   Bullerdiek, Joern ^a,f   Mohamed, Salah A ^b  

^a UNIVERSITY OF BREMEN   (Germany)

^b University of Schleswig Holstein Campus Luebeck ^*  (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Institute of Experimental and Clinical Pharmacology and Toxicology   (Germany)

^e Institute of Haematopathology   (Germany)

^f UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Acute aortic dissection; EMT endMT; HMGA2; Vasa vasorum

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; VIMENTIN;

ADULT; AORTA ANEURYSM; ARTICLE; DISSECTING ANEURYSM; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; UPREGULATION; VASA VASORUM; VASCULAR ENDOTHELIUM;

ADULT; ANEURYSM, DISSECTING; AORTIC ANEURYSM; ENDOTHELIUM, VASCULAR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; HMGA2 PROTEIN; HUMANS; MALE; MIDDLE AGED; TRANSCRIPTION FACTORS; UP-REGULATION; VASA VASORUM; VIMENTIN;

EID: 80053190418     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Abbara S., Kalva S., Cury R.C. and Isselbacher E.M. (2007). Thoracic aortic disease: spectrum of multidetector computed tomography imaging findings. J. Cardiovasc. Comput. Tomogr. 1, 40-54.
2. Abe N., Watanabe T., Suzuki Y., Matsumoto N., Masaki T., Mori T., Sugiyama M., Chiappetta G., Fusco A. and Atomi Y. (2003). An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue. Br. J. Cancer 89, 2104-2109.
3. Anand A. and Chada K. (2000). In vivo modulation of Hmgic reduces obesity. Nat. Genet. 24, 377-380.
4. Aravind L. and Landsman D. (1998). AT-hook motifs identified in a wide variety of DNA-binding proteins. Nucleic Acids Res. 26, 4413-4421.
5. Belge G., Meyer A., Klemke M., Burchardt K., Stern C., Wosniok W., Loeschke S. and Bullerdiek J. (2008). Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias. Genes Chromosomes Cancer 47, 56-63.
6. Beroukhim R.S., Kruzick T.L., Taylor A.L., Gao D. and Yetman A.T. (2006). Progression of aortic dilation in children with a functionally normal bicuspid aortic valve. Am. J. Cardiol. 98, 828-830.
7. Borrmann L., Schwanbeck R., Heyduk T., Seebeck B., Rogalla P., Bullerdiek J. and Wisniewski J.R. (2003). High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity. Nucleic Acids Res. 31, 6841-6851.
8. Chiappetta G., Avantaggiato V., Visconti R., Fedele M., Battista S., Trapasso F., Merciai B.M., Fidanza V., Giancotti V., Santoro M., Simeone A. and Fusco A. (1996). High level expression of the HMGI (Y) gene during embryonic development. Oncogene 13, 2439-2446.
9. Chin M.T., Pellacani A., Hsieh C.M., Lin S.S., Jain M.K., Patel A., Huggins G.S., Reeves R., Perrella M.A. and Lee M.E. (1999). Induction of high mobility group I architectural transcription factors in proliferating vascular smooth muscle in vivo and in vitro. J. Mol. Cell Cardiol. 31, 2199-2205.
10. Dietz H.C. and Pyeritz R.E. (1995). Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum. Mol. Genet. 4 Spec. No., 1799-1809.
11. Dietz H.C., Cutting G.R., Pyeritz R.E., Maslen C.L., Sakai L.Y., Corson G.M., Puffenberger E.G., Hamosh A., Nanthakumar E.J. and Curristin S.M. (1991). Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352, 337-339.
12. Dietz H.C., Ramirez F. and Sakai L.Y. (1994). Marfan's syndrome and other microfibrillar diseases. Adv. Hum. Genet. 22, 153-186.
13. Fusco A. and Fedele M. (2007). Roles of HMGA proteins in cancer. Nat. Rev. Cancer 7, 899-910.
14. Grundmann U., Lausberg H. and Schafers H.J. (2006). Acute aortic dissection. Differential diagnosis of a thoracic emergency. Anaesthesist 55, 53-63.
15. Guo D.C., Pannu H., Tran-Fadulu V., Papke C.L., Yu R.K., Avidan N., Bourgeois S., Estrera A.L., Safi H.J., Sparks E., Amor D., Ades L., McConnell V., Willoughby C.E., Abuelo D., Willing M., Lewis R.A., Kim D.H., Scherer S., Tung P.P., Ahn C., Buja L.M., Raman C.S., Shete S.S. and Milewicz D.M. (2007). Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat. Genet. 39, 1488-93.
16. Isselbacher E.M. (2007). Dissection of the descending thoracic aorta: looking into the future. J. Am. Coll. Cardiol. 50, 805-807.
17. Januzzi J.L., Isselbacher E.M., Fattori R., Cooper J.V., Smith D.E., Fang J., Eagle K.A., Mehta R.H., Nienaber C.A. and Pape L.A. (2004). Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD). J. Am. Coll. Cardiol. 43, 665-669.
18. Kim E.S., Kim M.S. and Moon A. (2004). TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int. J. Oncol. 25, 1375-1382.
19. Kokudo T., Suzuki Y., Yoshimatsu Y., Yamazaki T., Watabe T. and Miyazono K. (2008). Snail is required for TGFbeta-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells. J. Cell Sci. 121, 3317-3324.
20. Lee J.M., Dedhar S., Kalluri R. and Thompson E.W. (2006). The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 172, 973-981.
21. Lee Y.S. and Dutta A. (2007). The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 21, 1025-1030.
22. Merika M. and Thanos D. (2001). Enhanceosomes. Curr. Opin. Genet. Dev. 11, 205-208.
23. Mohamed S.A., Misfeld M., Richardt D. and Sievers H.H. (2008). Identification of candidate biomarkers of acute aortic dissection. Recent Patents DNA Gene Sequences 2, 61-65.
24. Mohamed S.A., Sievers H.H., Hanke T., Richardt D., Schmidtke C., Charitos E.I., Belge G. and Bullerdiek J. (2009). Pathway analysis of differentially expressed genes in patients with acute aortic dissection. Biomark. Insights 4, 81-90.
25. Moiseeva E.P. (2001). Adhesion receptors of vascular smooth muscle cells and their functions. Cardiovasc. Res. 52, 372-386.
26. Monzen K., Ito Y., Naito A.T., Kasai H., Hiroi Y., Hayashi D., Shiojima I., Yamazaki T., Miyazono K., Asashima M., Nagai R. and Komuro I. (2008). A crucial role of a high mobility group protein HMGA2 in cardiogenesis. Nat. Cell. Biol. 10, 567-574.
27. Motoyama K., Inoue H., Nakamura Y., Uetake H., Sugihara K. and Mori M. (2008). Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin. Cancer Res. 14, 2334-2340.
28. Neptune E.R., Frischmeyer P.A., Arking D.E., Myers L., Bunton T.E., Gayraud B., Ramirez F., Sakai L.Y. and Dietz H.C. (2003). Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat. Genet. 33, 407-411.
29. Nienaber C.A. and Sievers H.H. (2002). Intramural hematoma in acute aortic syndrome: more than one variant of dissection? Circulation 106, 284-285.
30. Peinado H., Portillo F. and Cano A. (2004). Transcriptional regulation of cadherins during development and carcinogenesis. Int. J. Dev. Biol. 48, 365-375.
31. Robinson P.N., Arteaga-Solis E., Baldock C., Collod-Beroud G., Booms P., De P.A., Dietz H.C., Guo G., Handford P.A., Judge D.P., Kielty C.M., Loeys B., Milewicz D.M., Ney A., Ramirez F., Reinhardt D.P., Tiedemann K., Whiteman P. and Godfrey M. (2006). The molecular genetics of Marfan syndrome and related disorders. J. Med. Genet. 43, 769-787.
32. Rogalla P., Drechsler K., Frey G., Hennig Y., Helmke B., Bonk U. and Bullerdiek J. (1996). HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am. J. Pathol. 149, 775-779.
33. Silverman D.I., Burton K.J., Gray J., Bosner M.S., Kouchoukos N.T., Roman M.J., Boxer M., Devereux R.B. and Tsipouras P. (1995). Life expectancy in the Marfan syndrome. Am. J. Cardiol. 75, 157-160.
34. Smalheiser N.R. and Torvik V.I. (2004). A population-based statistical approach identifies parameters characteristic of human microRNA-mRNA interactions. BMC Bioinformatics 5, 139.
35. Tan R.S. and Pu S.J. (2004). Is it andropause? Recognizing androgen deficiency in aging men. Postgrad. Med. 115, 62-66.
36. Thuault S., Valcourt U., Petersen M., Manfioletti G., Heldin C.H. and Moustakas A. (2006). Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. J. Cell Biol. 174, 175-183.
37. Tsai T.T., Nienaber C.A. and Eagle K.A. (2005). Acute aortic syndromes. Circulation 112, 3802-3813.
38. Valcourt U., Kowanetz M., Niimi H., Heldin C.H. and Moustakas A. (2005). TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol. Biol. Cell 16, 1987-2002.
39. Wheat M.W. Jr. (1987). Acute dissection of the aorta. Cardiovasc. Clin. 17, 241-262.
40. Zeisberg E.M., Tarnavski O., Zeisberg M., Dorfman A.L., McMullen J.R., Gustafsson E., Chandraker A., Yuan X., Pu W.T., Roberts A.B., Neilson E.G., Sayegh M.H., Izumo S. and Kalluri R. (2007). Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13, 952-961.
41. Zhou X., Benson K.F., Ashar H.R. and Chada K. (1995). Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376, 771-774.